Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s00280-016-3182-8
Published Online: 2016-10-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Passey, Chaitali
Darbenzio, Raymond
Jou, Ying-Ming
Lynch, Mark
Gupta, Manish
Funding for this research was provided by:
Bristol-Myers Squibb
License valid from 2016-10-28